首页> 外国专利> 20,21-Dinoreburnamine derivatives substituted in position 15, process for their preparation and the intermediate compounds thus obtained, their use as medicaments and compositions containing them

20,21-Dinoreburnamine derivatives substituted in position 15, process for their preparation and the intermediate compounds thus obtained, their use as medicaments and compositions containing them

机译:在15位取代的20,21-二氨基再燃胺衍生物,其制备方法以及由此获得的中间体化合物,其用作药物和包含它们的组合物的用途

摘要

The products of formula (I): IMAGE in which X1, X2 and X3, which may be identical or different, represent a hydrogen atom, a halogen atom, an alkyl, alkenyl or alkynyl radical containing at most 18 carbon atoms and optionally substituted, an alkoxy radical containing at most 7 carbon atoms and optionally substituted, a hydroxyl, trifluoromethyl or nitro radical, an amino or mono- or dialkylamino radical or an optionally substituted phenyl radical, and in which IMAGE represents A) either the group IMAGE in which A represents: a) an alkyl, alkenyl or alkynyl radical containing at most 7 carbon atoms and optionally substituted, b) an optionally substituted phenyl radical; B) or the group IMAGE in which R1 represents one of the two groups IMAGE in which one of the radicals R8 and R9 represents a hydrogen atom, an alkyl, alkenyl or alkynyl radical containing at most 6 carbon atoms and optionally substituted, an optionally substituted phenyl radical, an esterified carboxyl radical, a cyano radical or an acyl radical having from 2 to 6 carbon atoms, and the other of the radicals R8 and R9 represents a hydrogen atom, an alkyl, alkenyl or alkynyl radical containing at most 6 carbon atoms and optionally substituted or an optionally substituted phenyl radical, and R10 represents a hydrogen atom, an alkyl, alkenyl or alkynyl radical containing at most 5 carbon atoms and optionally substituted, or an optionally substituted phenyl radical. These products possess advantageous pharmacological properties which justify their use as medicaments.
机译:式(I)的产物:,其中X 1,X 2和X 3可以相同或不同,表示氢原子,卤素原子,烷基,烯基或炔基,至多含有18个碳原子,并且任选地取代的,至多含7个碳原子的烷氧基和任选取代的羟基,三氟甲基或硝基,氨基或单或二烷基或二烷基氨基或任选取代的苯基,并且其中代表A) ,其中A表示:a)含至多7个碳原子并且任选取代的烷基,烯基或炔基,b)任选取代的苯基; B)或基团,其中R1代表两个基团,其中基团R8和R9之一代表氢原子,烷基,烯基或炔基,至多含6个碳原子,且可任选取代,具有2至6个碳原子的任选取代的苯基基团,酯化的羧基基团,氰基基团或酰基基团,并且基团R8和R9中的另一个表示氢原子,包含至少一个的碳原子的烷基,烯基或炔基最多6个碳原子和任选取代或任选取代的苯基基团,且R 10代表氢原子,含有至多5个碳原子和任选取代的烷基,烯基或炔基或任选取代的苯基基团。这些产品具有有利的药理性质,证明其可作为药物使用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号